Lumos Pharma Inc to Host Virtual KOL Event Transcript
Good afternoon and welcome to the Lumos Pharma KOL call. At this time, all participants are in a listen only mode. A Q&A session will follow the formal presentation. (Operator Instructions) As a reminder, this event is being recorded and a replay will be available on the Lumos website following the conclusion of the call.
I would now like to turn the call over to your host, Rick Hawkins, CEO and Chairman of Lumos. Please go ahead.
Let move. Thank you, Sarah, and good afternoon, and thank you for joining our key opinion leader call for a review of our top line Phase 2 data evaluating our oral therapeutic candidate LUM-201 for Moderate Pediatric Growth Hormone Deficiency or PGHD. Additional analyses not previously disclosed will also be reviewed by these distinguished leaders in the field of pediatric endocrinology.
As a reminder, this conference call is being recorded. In addition, certain statements made during the call are forward-looking statements under US federal securities laws. Please
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
